MIR182 - microRNA 182 Gene
Also Known as MIRN182; mir-182; miRNA182
Species: Homo sapiens
About MIR182
This gene has 1 transcript (splice variant).
Summary
MicroRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted MicroRNA stem-loop. [provided by RefSeq, Sep 2009]
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables mRNA base-pairing translational repressor activity |
IDA
IDA: Inferred from direct assay
|
19188590 | GOA |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Glioblastoma |
|
|
| Melanoma |
|
|
| Lipoprotein Quantitative Trait Locus |
|
|
| Breast Cancer |
|
|
| Kidney Cancer |
|
|
| Prostate Cancer |
|
|
| Leukemia, Acute Myeloid |
|
|
| Lung Cancer |
|
|
| Colorectal Cancer |
|
|
| Retinitis Pigmentosa |
|
|
| Hepatocellular Carcinoma |
|
|
| Childhood Testicular Germ Cell Tumor |
|
|
| Respiratory System Cancer |
|
|
| Male Reproductive System Disease |
|
|
| Infratentorial Cancer |
|
|
| Posterior Uveal Melanoma |
|
|
| Male Reproductive Organ Cancer |
|
|
| Deafness, Autosomal Dominant 50 |
|
|
| Retinitis Pigmentosa 11 |
|
|
| Reproductive System Disease |
|
|
| Female Reproductive System Disease |
|
|
| Ovarian Disease |
|
|
| Bladder Disease |
|
|
| Respiratory System Disease |
|
|
| Thoracic Cancer |
|
|
| Ovary Epithelial Cancer |
|
|
| Prostate Disease |
|
|
| Large Intestine Cancer |
|
|
| Endocrine System Disease |
|
|
| Colonic Disease |
|
|
| Medulloblastoma |
|
|
| Central Nervous System Cancer |
|
|
| Bone Sarcoma |
|
|
| Intestinal Disease |
|
|
| Urinary System Disease |
|
|
| Large Cell Carcinoma |
|
|
| Gastrointestinal System Cancer |
|
|
| Esophageal Disease |
|
|
| Connective Tissue Cancer |
|
|
| Breast Disease |
|
|
| Uterine Anomalies |
|
|
| Gastrointestinal System Disease |
|
|
| Oral Cavity Cancer |
|
|
| Stomach Disease |
|
|
| Endocrine Gland Cancer |
|
|
| Bone Cancer |
|
|
| Arteries, Anomalies Of |
|
|
| Microphthalmia |
|
|
| Spinal Disease |
|
|
| Glucose Metabolism Disease |
|
|
| Lung Squamous Cell Carcinoma |
|
|
| Inherited Metabolic Disorder |
|
|
| Carbohydrate Metabolic Disorder |
|
|
| Lymphatic System Cancer |
|
|
| Lymphatic System Disease |
|
|
| Esophageal Cancer |
|
|
| Renal Cell Carcinoma, Nonpapillary |
|
|
| Brain Cancer |
|
|
| Wilms Tumor 1 |
|
|
| Oral Squamous Cell Carcinoma |
|
|
| Lung Cancer Susceptibility 3 |
|
|
| Connective Tissue Disease |
|
|
| Nervous System Disease |
|
|
| Leukemia, Chronic Lymphocytic |
|
|
| Type 2 Diabetes Mellitus |
|
|